Skip to main navigation
Release Details
MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.
About SpotRx
SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.
SOURCE MedAvail Holdings, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005184/en/
Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com
Source: MedAvail Holdings Inc.
1.877.830.0826
info@medavail.com
ir@medavail.com
Home office:
4720 E. Cotton Gin Loop
Suite 220
Phoenix, AZ 85040
Canada office:
6665 Millcreek Dr. Unit 1
Mississauga, ON L5N 5M4 Canada
Sorry. You must be logged in to view this form.
Footer Nav 2
© 2023 MedAvail Technologies, Inc. All rights reserved.